Original Paper : Newborn Calf Serum Retards Loss of the Chondrocytic Phenotype during In Vitro Cell Expansion
의약학 > 의공학
( Jung Sun Lee ) , ( Jin Yeon Lee ) , ( Eun Kyung Lee ) , ( Young Sook Son )
조직공학과 재생의학 2009년, 제6권 제1호, 229~235페이지(총7페이지)
2a800333.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    135원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    Chondrocytes isolated from cartilage tissue lose their chondrocytic phenotype during in vitro cell expansion, an event which has severely limited the advancement of tissue engineered cartilage and chondrocyte cell therapy. In an attempt to retard this loss of phenotype, we cultured costal chondrocytes in a supplementation of newborn calf serum(NCS) as opposed to the more commonly used fetal bovine serum(FBS). The costal chondrocytes cultured in the NCS medium maintained their chondrocytic phenotype longer than those cultured in the FBS medium, resulting in approximately five fold more cells expressing type II collagen and maintaining a round chondrocytic morphology after 3 weeks in culture. To evaluate their redifferentiation, the expanded chondrocytes were then seeded on a chitosan scaffold and cultured under NCS or FBS conditions. The differential effect of NCS on the maintenance of chondrocytic phenotype was also manifest in the high density three-dimensional culture, as evident by higher sustained expression of glucosaminoglycan than that seen in FBS medium. These results suggest that either FBS may act to stimulate the fibroblastic conversion of chondrocytes or that NCS may serve to retard it.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.